Studies show telemedicine increased therapy access 30% during pandemic, but mainly benefited wealthy, white, urban patients ...

UnitedHealth CEO Witty addresses healthcare issues post Brian Thompson's killing, emphasizes existing solutions and defends ...

Novartis is the latest drugmaker to sue the government for allegedly rejecting its proposed model to distribute federal drug ...

Most clinical trials for Huntington’s disease have run aground in the last few years, but academic researchers haven’t been ...

US regulators have rejected a T cell therapy for a rare and serious transplant complication related to Epstein-Barr virus ...

It’s time for one last look at the biotech numbers for 2024. And you might be surprised by some bullish charts below — ...

Johnson & Johnson, AstraZeneca and Pfizer leaders reiterated during the JP Morgan Healthcare Conference that the federal ...

The FDA approved Eli Lilly’s Omvoh in Crohn’s disease, the company announced Wednesday, handing the drug its second ...

The Department of Health and Human Services says Vertex is 'grasping at straws' in a lawsuit challenging the agency’s ...

The Drug Enforcement Administration has issued a long-awaited proposed rule that would create a permanent process for ...

FDA details rejection of Vanda Pharmaceuticals' gastroparesis drug tradipitant, citing failed pivotal trial vs. placebo and ...

Vaccine tech company Micron Biomedical has started 2025 on a positive note, raising over $16 million in a Series A extension round. The funding will be used to manufacture its ...